Summary Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd, a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentrates on the development of drugs. It offers services such as drug prototype development, pre-formulation,formulation development, analytical method development and validation, process optimization, stability testing and storage, and scale-up. Kemwell provides comparator product modification for blinding studies, lab and pilot scale manufacture, clinical packaging and labeling, registration batch manufacture, and technology transfer. The organization offers products in dosage forms of oral, semi-solids, liquids, parenteral and first-in-human formulations. It operates in India, Sweden and the US. Kemwell is headquartered in Bangalore, Karnataka, India. Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over... Research Beam Model: Research Beam Product ID: 1995769 250 USD New
Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 18
  • Publisher : GlobalData
 
 
 
Summary

Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd, a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentrates on the development of drugs. It offers services such as drug prototype development, pre-formulation,formulation development, analytical method development and validation, process optimization, stability testing and storage, and scale-up. Kemwell provides comparator product modification for blinding studies, lab and pilot scale manufacture, clinical packaging and labeling, registration batch manufacture, and technology transfer. The organization offers products in dosage forms of oral, semi-solids, liquids, parenteral and first-in-human formulations. It operates in India, Sweden and the US. Kemwell is headquartered in Bangalore, Karnataka, India.

Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Acquisition 10
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd - Key Competitors 14
Kemwell Biopharma Pvt Ltd - Key Employees 15
Kemwell Biopharma Pvt Ltd - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
May 17, 2017: Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd, Key Competitors 14
Kemwell Biopharma Pvt Ltd, Key Employees 15
List of Figures
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter